Skip to main content
logo
Shield Therapeutics plc (AIM:STX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
3.950
-0.450 (-10.23%)
Jul 31, 2026, 5:06 PM GMT

Shield Therapeutics Revenue

In the year 2025, Shield Therapeutics had annual revenue of $49.70M USD with 54.45% growth. Shield Therapeutics had revenue of $28.25M in the half year ending December 31, 2025, with 202.44% growth.

Revenue
$49.70M
Revenue Growth
+54.45%
P/S Ratio
1.14
Revenue / Employee
$814.77K
Employees
61
Market Cap
42.20M GBP

Revenue Chart

Chart
* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202549.70M17.52M54.45%
Dec 31, 202432.18M19.10M145.93%
Dec 31, 202313.09M7.59M137.95%
Dec 31, 20225.50M3.45M167.76%
Dec 31, 20212.05M-12.15M-85.54%
Dec 31, 202014.20M13.25M1,389.43%
Dec 31, 2019953.46K-14.18M-93.70%
Dec 31, 201815.13M14.27M1,657.92%
Dec 31, 2017860.83K485.65K129.44%
Dec 31, 2016375.19K--
Dec 31, 2015---
Dec 31, 2014---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Haleon11.15B
Hikma Pharmaceuticals2.49B
HUTCHMED (China)413.87M
Animalcare Group89.11M
ECO Animal Health Group87.53M
Allergy Therapeutics57.29M
Venture Life Group35.17M
Chill Brands Group955.18K
Revenue Rankings

Shield Therapeutics News

More News